1.Kunin, CM, Tupasi, T, Craig, WA. Use of antibiotics. A brief exposition of the problem and some tentative solutions. Ann Intern Med 1973;79:555–560.
2.Simmons, HE, Stolley, PD. This is medical progress? Trends and consequences of antibiotic use in the United States. J AMA 1974;227:1023–1028.
3.Buckwold, FJ, Ronald, AR. Antimicrobial misuse—effects and suggestions for control. J Antimicrob Chemother 1979;5:129–136.
4.Cooke, DM, Salter, AJ, Phillips, I. Antimicrobial misuse, antibiotic policies and information resources. J Antimicrob Chemother 1980;6:435–443.
5.Geddes, AM. Good antimicrobial prescribing. Introduction. Lancet 1982;2:82.
6.Cooke, DM, Salter, AJ, Phillips, I. The impact of antibiotic policy on prescribing in a London teaching hospital. A one-day prevalence survey as an indicator of antibiotic use. J Antimicrob Chemother 1983;11:447–453.
7.Massari, P, Czernichow, P, Manouvrier, C, Lecomte, F, Auger, MP, Humbert, G, et al. Evaluation and utilization patterns of antibiotic therapy. A study in 4 hospital departments. Rev Epidemiol Sante Publique 1993;41:161–168.
8.Gould, IM. Stewardship of antibiotic use and resistance surveillance: the international scene. J Hosp Infect 1999;43:S253–S260.
9.Jarvis, WR. Preventing the emergence of multidrug-resistant microorganisms through antimicrobial use controls: the complexity of the problem. Infect Control Hosp Epidemiol 1996;17:490–495.
10.McGowan, JE Jr. Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Rev Infect Dis 1983;5:1033–1048.
11.Marr, JJ, Moffet, HL, Kunin, CM. Guidelines for improving the use of antimicrobial agents in hospitals: a statement by the Infectious Diseases Society of America. J Infect Dis 1988;157:869–876.
12.Shlaes, DM, Gerding, DN, John, JF Jr, Craig, WA, Bornstein, DL, Duncan, RA, et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Infect Control Hosp Epidemiol 1997;18:275–291.
13.Nicolle, LE, Bentley, D, Garibaldi, R, Neuhaus, E, Smith, P, SHEA Long-Term-Care Committee. Antimicrobial use in long-term-care facilities. Infect Control Hosp Epidemiol 1996;17:119–128.
14.Goldmann, DA, Weinstein, RA, Wenzel, RP, Tablan, AC, Duma, RJ, Gaynes, RP, et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals: a challenge to hospital leadership. JAMA 1996;275:234–240.
15.Sohn, AH, Sinkowitz-Cochran, RL, Jarvis, WR. Program Overview: the Reality Check Sessions at the 4th Decennial International Conference on Nosocomial and Healthcare-Associated Infections. Infect Control Hosp Epidemiol 2000;21:742–744.
16.Duncan, RAControlling use of antimicrobial agents. Infed Control Hosp Epidemiol 1997;18:260–266.
17.Coignard, B, Trick, WE, DeMarais, PL, Vernon, M, Schwartz, D, Wojslaw, Aet al. Analysis of antibiotic use in a long-term care facility: identifying opportunities for improvement. Infect Control Hosp Epidemiol 2000;21:115. Abstract.
18.Burke, JP, Pestotnik, SL. Antibiotic use and microbial resistance in intensive care units: impact of computer-assisted decision support. J Chemother 1999;11:530–535.
19.John, JF Jr, Fishman, NO. Programmatic role of the infectious diseases physician in controlling antimicrobial costs in the hospital. Clin Infed Dis 1997;24:471–485.
20.Sturm, AW. Effects of a restrictive antibiotic policy on clinical efficacy of antibiotics and susceptibility patterns of organisms. Eur J Clin Microbiol Infect Dis 1990;9:381–389.
21.Sturm, AW. Rational use of antimicrobial agents and diagnostic microbiology facilities. J Antimicrob Chemother 1988;22:257–260.
22.Campo, L, Mylotte, JM. Use of microbiology reports by physicians in prescribing antimicrobial agents. Am J Med Sci 1988;296:392–398.
23.Chren, MM, Landefeld, CS. Physician's behavior and their interactions with drug companies. A controlled study of physicians who requested additions to a hospital drug formulary. JAMA 1994;271:684–689.
24.Evans, RS, Pestotnik, SL, Burke, JP, Gardner, RM, Larsen, RA, Classen, DC. Reducing duration of prophylactic antibiotic use through computer monitoring of surgical patients. DICP Ann Pharmacother 1990;24:351–354.
25.Singer, MV, Haft, R, Barlam, T, Aronson, M, Shafer, A, Sands, KE. Vancomycin control measures at a tertiary-care hospital: impact of interventions on volume and patterns of use. Infect Control Hosp Epidemiol 1998;19:248–253.
26.Sanchez, PJ, Mohamed, WA, Gard, JW, Gaffney, D, Byrd, L, Zeray, F, et al. Vancomycin-reduction protocol in a neonatal intensive care unit: what's the outcome? Presented at the 37th Annual Meeting of the Infectious Diseases Society of America; 1999; Philadelphia, PA. Abstract 550.
27.Durbin, WA Jr, Lapidas, B, Goldmann, DA. Improved antibiotic usage following introduction of a novel prescription system. JAMA 1981;246:1796–1800.
28.McGowan, JE. Do intensive hospital antibiotic control programs prevent the spread of antibiotic resistance? Infect Control Hosp Epidemiol 1994;15:478–483.